UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017972
Receipt number R000020825
Scientific Title Biological marker predicts response to immunosuppressive therapy in pediatric aplastic anemia.
Date of disclosure of the study information 2015/06/19
Last modified on 2015/12/20 22:54:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Biological marker predicts response to immunosuppressive therapy in pediatric aplastic anemia.

Acronym

Predicting the response IST in pediatric AA.

Scientific Title

Biological marker predicts response to immunosuppressive therapy in pediatric aplastic anemia.

Scientific Title:Acronym

Predicting the response IST in pediatric AA.

Region

Japan


Condition

Condition

Aplastic Anemia

Classification by specialty

Hematology and clinical oncology Pediatrics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To study the biological marker for the predicting the response to IST in pediatric AA.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The association between each biomarker and prognosis of IST.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 years-old <=

Age-upper limit

20 years-old >

Gender

Male and Female

Key inclusion criteria

Acqwired aplastic anemia
Less than 20 years old
Informed consent from patients and/or their parents

Key exclusion criteria

Congenital aplastic anemia, including Fanconii anemia, DKC etc.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hideki Muramatsu

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Pediatrics

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-2294

Email

hideki-muramatsu@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Atsushi Narita

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Pediatrics

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-2294

Homepage URL


Email

anarita@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Health Labour Sciences Research Grant

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 19 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Tha patients with shorter telomere length who had not minor PNH clone shows poor response to IST.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 06 Month 19 Day

Date of IRB


Anticipated trial start date

2015 Year 06 Month 19 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

113 patients were analyzed.


Management information

Registered date

2015 Year 06 Month 19 Day

Last modified on

2015 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020825


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name